(Q38065393)

28 August 2017

1 reference

title

HTLV-1: persistence and pathogenesis (English)

1 reference

Human T-lymphotropic virus 1

28 August 2017

0 references

0 references

Becca Asquith

4

0 references

Marjet Elemans

object named as

Marjet Elemans

series ordinal

2

0 references

Aileen Rowan

object named as

Aileen G Rowan

series ordinal

3

0 references

author name string

Lucy B Cook

series ordinal

1

1 reference

28 August 2017

language of work or name

English

0 references

publication date

1 January 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

435

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

131-140

1 reference

Valproate activates bovine leukemia virus gene expression, triggers apoptosis, and induces leukemia/lymphoma regression in vivo

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Ligand-independent exhaustion of killer immunoglobulin-like receptor-positive CD8+ T cells in human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Biology of T memory type 1 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

In vivo CD8+ T cell control of immunodeficiency virus infection in humans and macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, etc.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

CTL quality and the control of human retroviral infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Cutting edge: rapid in vivo killing by memory CD8 T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Features and distribution of CD8 T cells with human leukocyte antigen class I-specific receptor expression in chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 p24.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

An interaction between the human T cell leukemia virus type 1 basic leucine zipper factor (HBZ) and the KIX domain of p300/CBP contributes to the down-regulation of tax-dependent viral transcription by HBZ

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Human T cell lymphotropic virus type 1 viral load variability and long-term trends in asymptomatic carriers and in patients with human T cell lymphotropic virus type 1-related diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Revisiting the extracellular lifestyle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Why don't CD8+ T cells reduce the lifespan of SIV-infected cells in vivo?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

The efficiency of the human CD8+ T cell response: how should we quantify it, what determines it, and does it matter?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Quantification of the relative importance of CTL, B cell, NK cell, and target cell limitation in the control of primary SIV-infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

HTLV-I viral escape and host genetic changes in the development of adult T cell leukemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy/tropical spastic paraparesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Accumulation of human T-lymphotropic virus type I (HTLV-I)-infected cells in the cerebrospinal fluid during the exacerbation of HTLV-I-associated myelopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Persistent paradox of natural history of human T lymphotropic virus type I: parallel analyses of Japanese and Jamaican carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

The HBZ-SP1 isoform of human T-cell leukemia virus type I represses JunB activity by sequestration into nuclear bodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Double control systems for human T-cell leukemia virus type 1 by innate and acquired immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Immunological risks of adult T-cell leukemia at primary HTLV-I infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

The avidity and lytic efficiency of the CTL response to HTLV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

KIR and disease: a model system or system of models?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

CD8+ T-cell responses to different HIV proteins have discordant associations with viral load

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

5'-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Genetic stability of human T lymphotropic virus type I despite antiviral pressures by CTLs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Histone deacetylase mediated transcriptional activation reduces proviral loads in HTLV-1 associated myelopathy/tropical spastic paraparesis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

T-cell epitope prediction: rescaling can mask biological variation between MHC molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

HLA class I binding of HBZ determines outcome in HTLV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Estimating the effectiveness of simian immunodeficiency virus-specific CD8+ T cells from the dynamics of viral immune escape

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

HTLV-I proviral load correlates with progression of motor disability in HAM/TSP: analysis of 239 HAM/TSP patients including 64 patients followed up for 10 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Human T-Cell Lymphotropic Virus Type I and Neurological Diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

In contrast to HIV, KIR3DS1 does not influence outcome in HTLV-1 retroviral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Safety of long-term treatment of HAM/TSP patients with valproic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Nationwide survey of HTLV-I-associated myelopathy in Japan: association with blood transfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Expression of leukocyte immunoglobulin-like receptors and natural killer receptors on virus-specific CD8+ T cells during the evolution of Epstein-Barr virus-specific immune responses in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

The contribution of NF-kappa B activity to spontaneous proliferation and resistance to apoptosis in human T-cell leukemia virus type 1 Tax-induced tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Global epidemiology of HTLV-I infection and associated diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Interplay of natural killer cells and their receptors with the adaptive immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Estimation of the rate of killing by cytotoxic T lymphocytes in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Cutting edge: Ly49A inhibits TCR/CD3-induced apoptosis and IL-2 secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

HTLV-1 bZIP factor impairs cell-mediated immunity by suppressing production of Th1 cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Differential requirements for survival and proliferation of CD8 naïve or memory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Prospective study of HTLV-I infection in an initially asymptomatic cohort.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

HBZ interacts with JunD and stimulates its transcriptional activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Regulation of T cell function by NK cell receptors for classical MHC class I molecules.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Functional analysis of killer Ig-like receptor-expressing cytomegalovirus-specific CD8+ T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Natural killer cells act as rheostats modulating antiviral T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Clonal expansion of infected cells: a way of life for HTLV-I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

HTLV-1 bZIP factor enhances TGF-β signaling through p300 coactivator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.09.028

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2012.09.028

1 reference

28 August 2017

1 reference